Literature DB >> 21400222

Familial breast cancer: is it time to move from a reactive to a proactive role?

H Harris1, I Nippert, C Julian-Reynier, J Schmidtke, C van Asperen, D Gadzicki, A Tibben, D G Evans.   

Abstract

In 2004 the NICE guidelines on familial breast cancer advised Health Care Professionals that they should not actively seek to identify women with a family history of breast cancer. We have carried out a review of the evidence base and a large scale questionnaire survey of health professionals in four European countries. There is overwhelming support amongst GPs and surgeons against the premise that that health care professionals should not be proactive in identifying patients at risk of familial breast cancer. This that suggest the time is right to overturn the NICE decision.

Entities:  

Mesh：

Year:  2011        PMID： 21400222     DOI： 10.1007/s10689-011-9434-1

Source DB:  PubMed          Journal:  Fam Cancer        ISSN： 1389-9600            Impact factor:   2.375


  8 in total

1.  Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.

Authors:  Susan M Domchek; Tara M Friebel; Christian F Singer; D Gareth Evans; Henry T Lynch; Claudine Isaacs; Judy E Garber; Susan L Neuhausen; Ellen Matloff; Rosalind Eeles; Gabriella Pichert; Laura Van t'veer; Nadine Tung; Jeffrey N Weitzel; Fergus J Couch; Wendy S Rubinstein; Patricia A Ganz; Mary B Daly; Olufunmilayo I Olopade; Gail Tomlinson; Joellen Schildkraut; Joanne L Blum; Timothy R Rebbeck
Journal:  JAMA       Date:  2010-09-01       Impact factor: 56.272

2.  Decision analysis of prophylactic surgery or screening for BRCA1 mutation carriers: a more prominent role for oophorectomy.

Authors:  Mariëlle S van Roosmalen; Lia C G Verhoef; Peep F M Stalmeier; Nicoline Hoogerbrugge; Willem A J van Daal
Journal:  J Clin Oncol       Date:  2002-04-15       Impact factor: 44.544

3.  Effect of prevention strategies on survival and quality-adjusted survival of women with BRCA1/2 mutations: an updated decision analysis.

Authors:  Victor R Grann; Judith S Jacobson; Dustin Thomason; Dawn Hershman; Daniel F Heitjan; Alfred I Neugut
Journal:  J Clin Oncol       Date:  2002-05-15       Impact factor: 44.544

4.  Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS).

Authors:  M O Leach; C R M Boggis; A K Dixon; D F Easton; R A Eeles; D G R Evans; F J Gilbert; I Griebsch; R J C Hoff; P Kessar; S R Lakhani; S M Moss; A Nerurkar; A R Padhani; L J Pointon; D Thompson; R M L Warren
Journal:  Lancet       Date:  2005 May 21-27       Impact factor: 79.321

5.  Risk reducing mastectomy: outcomes in 10 European centres.

Authors:  D G R Evans; A D Baildam; E Anderson; A Brain; A Shenton; H F A Vasen; D Eccles; A Lucassen; G Pichert; H Hamed; P Moller; L Maehle; P J Morrison; D Stoppat-Lyonnet; H Gregory; E Smyth; D Niederacher; C Nestle-Krämling; J Campbell; P Hopwood; F Lalloo; A Howell
Journal:  J Med Genet       Date:  2008-11-07       Impact factor: 6.318

6.  Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition.

Authors:  Mieke Kriege; Cecile T M Brekelmans; Carla Boetes; Peter E Besnard; Harmine M Zonderland; Inge Marie Obdeijn; Radu A Manoliu; Theo Kok; Hans Peterse; Madeleine M A Tilanus-Linthorst; Sara H Muller; Sybren Meijer; Jan C Oosterwijk; Louk V A M Beex; Rob A E M Tollenaar; Harry J de Koning; Emiel J T Rutgers; Jan G M Klijn
Journal:  N Engl J Med       Date:  2004-07-29       Impact factor: 91.245

7.  Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study.

Authors:  Susan M Domchek; Tara M Friebel; Susan L Neuhausen; Theresa Wagner; Gareth Evans; Claudine Isaacs; Judy E Garber; Mary B Daly; Rosalind Eeles; Ellen Matloff; Gail E Tomlinson; Laura Van't Veer; Henry T Lynch; Olufunmilayo I Olopade; Barbara L Weber; Timothy R Rebbeck
Journal:  Lancet Oncol       Date:  2006-03       Impact factor: 41.316

8.  Mammographic surveillance in women younger than 50 years who have a family history of breast cancer: tumour characteristics and projected effect on mortality in the prospective, single-arm, FH01 study.

Authors: 
Journal:  Lancet Oncol       Date:  2010-11-17       Impact factor: 41.316
  8 in total
  5 in total

Review 1. 

Authors:  Ruth Heisey; June C Carroll
Journal:  Can Fam Physician       Date:  2016-10       Impact factor: 3.275

Review 2.  Identification and management of women with a family history of breast cancer: Practical guide for clinicians.

Authors:  Ruth Heisey; June C Carroll
Journal:  Can Fam Physician       Date:  2016-10       Impact factor: 3.275

Review 3.  Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized Medicine.

Authors:  Jeffrey N Weitzel; Kathleen R Blazer; Deborah J MacDonald; Julie O Culver; Kenneth Offit
Journal:  CA Cancer J Clin       Date:  2011-08-19       Impact factor: 508.702

4.  A primary care audit of familial risk in patients with a personal history of breast cancer.

Authors:  Paul Nathan; Aneeta Ahluwalia; Wendy Chorley
Journal:  Fam Cancer       Date:  2014-12       Impact factor: 2.375

5.  Targeting breast cancer outcomes-what about the primary relatives?

Authors:  Alison Johnston; Michael Sugrue
Journal:  Mol Genet Genomic Med       Date:  2017-05-31       Impact factor: 2.183
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.